The influence of insulin and incretin-based therapies on renal tubular transport
Journal of Nephrology · 2024
DOI: 10.1007/s40620-024-02048-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Erica Rosati und 3 weiteren Autor:innen. Beteiligte Einrichtung: U.O.S. Terapia Conservativa della Malattia Renale Cronica, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gem…. Hauptthemen laut MEDLINE: Kidney Tubules, Incretins, Insulin, Glucagon-Like Peptide-1 Receptor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Verona.
Abstract (Originalsprache)
The tubular function of the kidney is very complex and is finely regulated by many factors. These include a variety of hormonal signaling pathways which are involved in the expression, activation and regulation of renal transporters responsible for the handling of electrolytes. Glucose-lowering drugs such as insulin and incretin-based therapies, exert a well-known renal protective role in diabetic kidney disease, mainly acting at the glomerular level. In the literature, several studies have described the effect of insulin and the incretin hormones on tubular transport. Most of these studies focused on the variations in excretion and clearance of sodium but did not extensively and systematically investigate the possible variations that these hormones may induce in the tubular regulation of all the other electrolytes, urea metabolism, acid–base balance and urinary pH. While insulin action on the kidney is very well-described, the renal tubular impact of incretin-based therapies is less consistent and the results available are scarce. To our knowledge, this is the first review summarizing the effects induced on renal tubules by insulin, glucagon-like peptide-1 (GLP-1) receptor agonists and serine protease dipeptidyl peptidase-4 (DPP4) inhibitors in both healthy and diabetic human subjects. This is significant because it highlights the existence of a renal-gut and pancreas axis which also has a direct tubular effect and enables a deeper understanding of renal physiology. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- U.O.S. Terapia Conservativa della Malattia Renale Cronica, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
- Endocrinologia e Diabetologia, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
- Digestive Disease Center, Pancreas Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Section of Nephrology, Department of Medicine, Università degli Studi di Verona, Verona, Italy. pietromanuel.ferraro@univr.it.
ORCID-Profile: Pietro Manuel Ferraro
Förderung
- Università degli Studi di Verona
Zitieren
APA
Rosati, E., Di Giuseppe, G., Mezza, T., & Ferraro, P. M. (2024). The influence of insulin and incretin-based therapies on renal tubular transport. Journal of Nephrology. https://doi.org/10.1007/s40620-024-02048-w
Vancouver
Rosati E, Di Giuseppe G, Mezza T, Ferraro PM. The influence of insulin and incretin-based therapies on renal tubular transport. Journal of Nephrology. 2024. doi:10.1007/s40620-024-02048-w
BibTeX
@article{Rosati2024,
author = {Rosati, Erica and Di Giuseppe, Gianfranco and Mezza, Teresa and Ferraro, Pietro Manuel},
title = {The influence of insulin and incretin-based therapies on renal tubular transport},
journal = {Journal of Nephrology},
year = {2024},
doi = {10.1007/s40620-024-02048-w}
}
EUVIMED